What We Do

What We Do

Prevent Duplicate and Professional Subjects From Enrolling In Your Clinical Trials​

Prevent Duplicate and Professional Subjects From Enrolling In Your Clinical Trials

Verified Clinical Trials helps sponsors and research sites detect and prevent poor quality professional or duplicate subjects from entering their clinical trials at the time of screening. And, the protections continue the entire duration of the study. Duplicate or professional research subjects result in failed clinical trials. VCT also detects and prevents 17 other important potential protocol violations. The protections continue the entire duration of the study. The verification is instantaneous and informative.

VCT provides the research sites with the tool they never had before. VCT delivers an expedient method to establish the current enrollment status of research subjects presenting for their clinical trials. Poor quality professional research subjects provide factitious information to the research site staff in order to remain enrolled in the study. In these instances, this will skew the data integrity raising placebo rates. Verified Clinical Trials will prevent these issues from occuring.

Reduce Placebo Rates and Improve Data Integrity

Poor quality professional research subjects provide false anwers to the research site staff in order to remain in the study. In these instances, this will skew the data integrity raising placebo rates. Verified Clinical Trials will prevent these issues from occuring.

Insurance Policy For Your Clinical Trial

Did you ever wish you could have insurance for selecting better well qualified subjects for your studies? Well, VCT is indeed a low cost-effective insurance policy for your clinical trials. The VCT system is an excellent return on investment saving sponsors and sites time and money. Avoid fruitless efforts attempting to sort out if there are duplicates in your study. Why wait until the subject has been screened or progressed to further visits within your study and hope you can detect these issues at a later date or time? Why spend effort and money to screen patients that you may find out later are ineligible or likely to early terminate?
Use of the VCT database system will ensure the best quality research subjects are selected to participate in your study and will remain in your clinical trial in a time efficient and cost-effective manner. VCT will actually save sponsors money. And, by preventing just a few poor quality in eligible subjects from entering the clinical trial, not only do you protect your trial from failure, you will save time and money.

VCT detects poor quality ineligible subjects at the time of screening and the protections continue throughout the entire duration of the clinical trials.

Improve Study Data and Trial Outcomes

Verifying study subjects through Verified Clinical Trials’ processes helps to ensure high quality, and more accurate data collection while also protecting the safety of clinical trial volunteers. The VCT verification process is simple, yet thorough, and helps to promote the overall mission of clinical trials… to ultimately deliver safe and effective drugs to the market.

Without Verified Clinical Trials, study data accuracy and subject data is at risk. Poor quality or duplicate subjects oftentimes provide information that they believe will help keep them in the study. The professional subject will tell the research coordinator that they are feeling better or doing better. When in fact, these subjects are in the placebo arm, it raises the placebo rate and thereby causes issues with separation from placebo. 

Alternatively, if the research subject is on the placebo or low-dose arm and then travels to multiple sites within the clinical trial and is indeed taking the study medication at numerous sites within the same trail, this also raises a placebo rate or causes faulty data. When research subjects participate in numerous clinical trials and combine multiple investigational products, this may result in increased adverse events.

Integrations With Existing Clinical Systems

VCT’s state of the art technology platform seamlessly integrates with other clinical systems resulting in an effortless experience for all stakeholders. VCT has the ability to work with any IRT or clinical system to effortlessly keep research subject’s status updated as they move through the clinical trial. With a decade of experience, Verified Clinical Trials has integrated and worked with countless technologies. Verified Clinical Trials offers advanced integration platforms and methodology making the integration quick and easy.

One Touch System

VCT offers a one-touch expedient process for research sites, making the entire process rapid, simple and straightforward. In an instant, research sites will determine if the research subject is a good candidate to proceed in the trial based upon the research subjects past study participation and study history. Verification takes less than one minute. Following this verification, the research site does not need to complete any further tasks. Verified Clinical Trials state of the art technology and platform allows for swift results.

Save Time & Money

VCT detects duplicate subjects and professional research subjects as well as other protocol violations related to prior study participation at the time of screening. The protections continue the entire duration of the study. By preventing poor quality research subjects at the time of screening, sponsors save time and money. Expensive screening visits are curtailed and ongoing unnecessary visits and study activities are prevented. Ultimately, by helping select truly qualified research subjects for the clinical trial, the study has a better chance for success and for meeting primary and secondary endpoints. The Verified Clinical Trials system can save a clinical trial from failure costing many millions of dollars. VCT is a cost-effective excellent return on investment. VCT remains a low-cost insurance policy for your clinical trial.

Biometrics Verification Capabilities

Fingerprint Verification

VCT offers optional biometric fingerprint research subject verification technology that is like no other in the industry to detect professional research subjects in clinical trials. Cutting edge fingerprint verification eliminates issues with fake IDs to detect and prevent professional research subjects at the time of screening. The fingerprint verification improves accuracy and speed reducing transcription errors. VCT never actually collects or stores the actual fingerprint but creates a proprietary reproducible template that is encrypted as well. Easy and cost effective to setup. VCT’s biometric solutions comply with local privacy regulations and can be used around the globe to detect and prevent professional research subjects and duplicate research subjects from entering your clinical trials to improve overall safety and data quality.

  • Optional instant fingerprint biometric authentication
  • Improves speed and accuracy
  • Avoids Fake IDs

Facial Recognition

VCT’s optional facial recognition biometrics can be used for decentralized or virtual clinical trials or can be employed in traditional clinical trials at the research site. Biometric solutions increase speed and accuracy to make VCT the most advanced solution in the quest for optimal research subject selection to detect and prevent professional research subjects in clinical trials.

VCT’s biometric solutions eliminate issues with fake IDs and help select a better qualified subject for your trial. VCT has developed a mobile application platform that allows for fast and easy verifications even as the industry moves towards decentralized and virtual studies. VCT’s facial recognition platform can be utilized on any mobile device or tablet as well as a computer.

VCT’s biometric solutions comply with local privacy regulations and can be used around the globe to detect and prevent professional research subjects and duplicate research subjects from entering your clinical trials to improve overall safety and data quality.

Reduce Placebo Rates and Adverse Events

Imagine that upwards of 10% or more of your research participants are providing fake answers to the study coordinator. Study subjects that are untruthful about their concurrent participation in another drug trial are far more likely to report inaccurate efficacy results. Professional subjects may report efficacy simply to legitimize their participation for site staff. This false efficacy reporting is detrimental to the active comparator efficacy results and will raise placebo rates. Alternatively, if a research subject is participating in the same study at multiple sites because they fear they may be on placebo or low dose, they may be receiving too large a dose that may result in adverse events. Furthermore, we witness research subjects moving between various clinical trials across different therapeutic indications again ingesting investigational products with unknown interactions with other investigational products. This ultimately affects efficacy rates, placebo rates, and the incidence of adverse events. These issues can result in a clinical trials failure. By using the Verified Clinical Trials research subject database registry to prevent duplicate subjects and professional subjects, you can mitigate these issues.

World’s Largest and Most Comprehensive Research Subject Database Of Its Kind

The Most Widely Used Global Verification Service

VCT is by far the most widely used research subject verification service in the world and the only one of its kind. VCT is a global research subjects database registry and now operates in 50 countries. While VCT is utilized every day by the great majority of phase 1 units, VCT boasts the world’s largest and most comprehensive global research subject database encompassing phase II through phase IV clinical trials across multiple therapeutic indications. VCT offers the ability to follow your compound or investigational product from the phase 1 unit all the way through the development process. VCT is the largest and most comprehensive database of its kind, and the only database to cover phase I through phase IV globally.

The Largest CNS Database Worldwide

VCT is the world’s expert and leader when it comes to CNS and psychiatry clinical trials. Verified Clinical Trials is proud to state that the majority of sponsors conducting clinical trials in CNS and psychiatry utilize the Verified Clinical Trials global registry to detect and prevent duplicate subjects and professional research subjects around the world. VCT boasts the largest CNS and psychiatry clinical trials research subject database registry both in the United States and rest of world. The registry spans across the United States and 50 countries worldwide. There is no other company or system like Verified Clinical Trials.

Compliant with special regulatory processes in multiple countries around the world

Verified Clinical Trials has a proprietary system in place that has allowed the registry to operate in more than 50 countries around the globe. VCT continues to work with numerous ethics committees and regulators so that it may bring improved safety and data quality to the sponsors that conduct clinical trials around the world. No country or region is immune to the potential protocol violations such as duplicate enrollment and others.  VCT’s global coverage includes phase I and phase II and phase III studies across multiple therapeutic indications.  Detecting duplicate research subjects, or professional research subjects in clinical trials at the time of screening and continuing the protections then entire duration of the trial.

Ensure Accurate Drug Safety Profiles

Based on many years of mature VCT data and experience, upwards of 10% or more may be duplicate research subjects or professional research subjects or potential protocol violations in your clinical trial. The consequences of this can be disastrous and can result in a clinical trials failure to meet its primary or secondary endpoints. There may be increased adverse events by combining multiple investigational products. So much time and money are spent planning and executing well-designed clinical trials. Why leave these issues to chance? There is a cost effective and easy to implement solution with an excellent return on investment by using VCT.
VCT detects these professional research subjects and issues at the time of screening and continues to protections the entire duration of the trial.